Meta-analysis of OncomineTM breast cancer patient microarray data showed a significant increase in SHARPIN expression in patients and SHARPIN expression affected metastasis free survival in breast cancer patients after adjuvant chemotherapy treatment as identified by SurvExpress [98]. This evidence concerns the gene SHARPIN and breast carcinoma.